Profile data is unavailable for this security.
About the company
Gentian Diagnostics ASA is a Norway-based company within health care sector. The Company develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The Company is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
- Revenue in NOK (TTM)172.52m
- Net income in NOK42.78m
- Incorporated2001
- Employees63.00
- LocationGentian Diagnostics ASABjornasveien 5MOSS 1596NorwayNOR
- Websitehttps://www.gentian.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q linea AB | 9.02m | -202.30m | 520.97m | 83.00 | -- | 2.02 | -- | 57.78 | -93.10 | -93.10 | 2.12 | 12.69 | 0.0571 | 0.5409 | 4.37 | 89,308.51 | -128.17 | -71.92 | -306.62 | -84.15 | -110.15 | -303.58 | -2,243.85 | -3,994.18 | 1.28 | -62.88 | 0.3537 | -- | -46.80 | 18.64 | 5.45 | -- | -49.88 | -- |
| Bactiguard Holding AB | 245.69m | -8.42m | 546.77m | 153.00 | -- | 1.82 | 12.97 | 2.23 | -0.2238 | -0.2238 | 6.53 | 8.99 | 0.381 | 3.44 | 6.91 | 1,495,216.00 | -1.31 | -8.02 | -1.86 | -10.13 | 63.78 | 48.56 | -3.43 | -25.10 | 1.38 | -0.3387 | 0.3410 | -- | -12.64 | 4.22 | 73.69 | -- | -17.92 | -- |
| Modulight Oyj | 77.46m | -52.81m | 566.10m | 71.00 | -- | 1.09 | -- | 7.31 | -0.1172 | -0.1172 | 0.1727 | 1.07 | 0.1254 | -0.7943 | 4.78 | 102,484.90 | -8.55 | -9.90 | -9.25 | -10.66 | 129.94 | 119.43 | -68.15 | -88.50 | 3.46 | -- | 0.081 | -- | 1.74 | -10.65 | 45.65 | -- | 24.38 | -- |
| Nanexa AB | 11.36m | -41.94m | 636.49m | 15.00 | -- | 7.66 | -- | 56.04 | -0.2644 | -0.2644 | 0.0694 | 0.4874 | 0.0972 | 24.67 | 1.54 | 813,538.40 | -35.91 | -37.21 | -42.59 | -44.95 | 69.56 | 93.79 | -369.29 | -355.05 | 2.07 | -21.98 | 0.2165 | -- | -16.93 | 70.11 | 67.40 | -- | 21.42 | -- |
| BioPorto A/S | 56.04m | -133.04m | 720.95m | 48.00 | -- | 12.28 | -- | 12.86 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
| OssDsign AB | 193.48m | -54.76m | 769.87m | 32.00 | -- | 2.31 | -- | 3.98 | -0.5493 | -0.5493 | 2.06 | 2.80 | 0.5109 | 0.3672 | 6.95 | 5,629,938.00 | -14.46 | -25.42 | -16.05 | -28.59 | 96.29 | 85.57 | -28.30 | -82.42 | 6.33 | -13.77 | 0.0044 | -- | 34.51 | 48.59 | -2.68 | -- | 24.28 | -- |
| Senzime AB (publ) | 96.34m | -129.54m | 791.03m | 50.00 | -- | 2.11 | -- | 8.21 | -0.8672 | -0.8672 | 0.6394 | 2.22 | 0.234 | 1.73 | 5.99 | 1,794,120.00 | -31.47 | -35.09 | -34.04 | -37.52 | 41.86 | 8.75 | -134.46 | -400.65 | 4.30 | -7.70 | 0.0399 | -- | 63.55 | 54.18 | 11.50 | -- | 40.12 | -- |
| Omda AS | 474.92m | -30.27m | 863.38m | 260.00 | -- | 25.36 | 29.13 | 1.82 | -1.51 | -1.51 | 23.59 | 1.63 | 0.6793 | 26.59 | 21.70 | 1,772,075.00 | -4.33 | -5.14 | -5.39 | -6.63 | 93.69 | 91.09 | -6.37 | -10.32 | 0.6483 | 0.5281 | 0.9359 | -- | 3.45 | 15.80 | -163.95 | -- | -15.57 | -- |
| Gentian Diagnostics ASA | 172.52m | 42.78m | 891.41m | 63.00 | 21.14 | 4.41 | 17.21 | 5.17 | 2.73 | 2.73 | 11.07 | 13.10 | 0.8181 | 1.63 | 7.83 | 2,738,365.00 | 20.29 | -2.99 | 22.99 | -3.36 | 55.06 | 44.66 | 24.80 | -5.84 | 4.16 | -- | 0.0094 | -- | 12.52 | 25.96 | 525.37 | -- | 22.08 | -- |
| Optomed Oyj | 199.05m | -65.79m | 950.74m | 112.00 | -- | 3.76 | -- | 4.78 | -0.2915 | -0.2915 | 0.8803 | 1.03 | 0.5847 | 2.40 | 5.47 | 151,147.80 | -19.33 | -14.59 | -23.47 | -17.41 | 64.64 | 65.60 | -33.05 | -31.36 | 1.60 | -20.89 | 0.1221 | -- | -0.3974 | 0.084 | -22.72 | -- | 8.10 | -- |
| Nexstim Oyj | 115.25m | -3.24m | 1.05bn | 40.00 | -- | 28.69 | 138.02 | 9.10 | -0.042 | -0.042 | 1.47 | 0.4426 | 0.8553 | 0.5613 | 4.66 | 251,616.80 | -2.40 | -12.40 | -4.17 | -20.76 | 94.36 | 95.09 | -2.81 | -16.29 | 1.08 | 0.7835 | 0.6002 | -- | 20.55 | 21.14 | 32.79 | -- | 15.13 | -- |
| Sedana Medical AB (publ) | 212.23m | -43.65m | 1.06bn | 117.00 | -- | 1.09 | -- | 5.00 | -0.4092 | -0.4092 | 1.99 | 9.14 | 0.2012 | 1.46 | 9.47 | 2,670,406.00 | -4.14 | -4.90 | -4.34 | -5.16 | 70.47 | 68.32 | -20.57 | -30.26 | 3.28 | -21.90 | 0.0045 | -- | 16.17 | 20.06 | 82.09 | -- | 26.45 | -- |
| C Rad AB | 491.56m | 24.97m | 1.12bn | 107.00 | 45.65 | 3.00 | 30.61 | 2.27 | 0.6922 | 0.6922 | 13.58 | 10.53 | -- | -- | -- | 4,623,273.00 | -- | 8.44 | -- | 11.73 | 51.45 | 45.00 | 5.08 | 8.28 | 2.98 | 3.31 | 0.0252 | 0.00 | 10.45 | 17.96 | 58.88 | -- | -9.15 | -- |
| ADDvise Group AB (publ) | 1.74bn | 4.62m | 1.12bn | 615.00 | 19.91 | 0.9402 | 9.37 | 0.6416 | 0.0864 | 0.0864 | 3.44 | 1.83 | 0.5167 | 7.91 | 4.96 | 2,534,790.00 | 0.1399 | 3.41 | 0.174 | 4.28 | 39.91 | 46.52 | 0.2708 | 6.06 | 0.7562 | 1.62 | 0.5251 | 0.4389 | 21.68 | 36.71 | -13.04 | 85.85 | 52.63 | -- |
| Paxman AB (publ) | 316.91m | 5.28m | 1.12bn | 142.00 | 163.24 | 2.45 | 42.50 | 3.55 | 0.2757 | 0.2757 | 14.26 | 18.38 | 0.8486 | 3.45 | 4.71 | 2,810,305.00 | 1.37 | 0.8426 | 1.60 | 1.20 | 67.34 | 68.75 | 1.61 | 0.7966 | 4.07 | 1.71 | 0.0245 | 0.00 | 20.41 | 24.30 | 382.55 | 70.92 | -3.73 | -- |
Data as of Feb 06 2026. Currency figures normalised to Gentian Diagnostics ASA's reporting currency: Norwegian Krone NOK
26.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Vatne Capital ASas of 31 Dec 2025 | 2.33m | 15.11% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 586.04k | 3.80% |
| Schroder Investment Management (Europe) SA (Finland)as of 30 Jun 2025 | 523.63k | 3.40% |
| DNB Asset Management ASas of 31 Dec 2025 | 359.03k | 2.33% |
| Rasmussengruppen ASas of 31 Dec 2025 | 208.42k | 1.35% |
| Lannebo Kapitalf�rvaltning AB (Sweden)as of 30 Nov 2025 | 154.34k | 1.00% |
| Equinor Asset Management ASAas of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
